Parker Waichman LLP

In Xarelto MDL, Judge Extends Deadline to File Complaints

Certain groups of plaintiffs in the Xarelto multidistrict litigation (MDL) have more time to file a lawsuit against manufacturers Janssen Pharmaceuticals and Bayer Healthcare. According to a recent order issued by Judge Eldon Fallon, who is overseeing the MDL in the Eastern District of Louisiana, the filing deadline has been extended for 90 days for […]

Certain groups of plaintiffs in the Xarelto multidistrict litigation (MDL) have more time to file a lawsuit against manufacturers Janssen Pharmaceuticals and Bayer Healthcare. According to a recent order issued by Judge Eldon Fallon, who is overseeing the MDL in the Eastern District of Louisiana, the filing deadline has been extended for 90 days for certain groups looking to sue over the blood thinner.

The order was issued after the first cases were selected for bellwether trials. The deadline was extended “due to an influx of complaints” in the clerk’s office, court records indicate. More than 7,000 lawsuits have been consolidated into the Xarelto MDL. The first lawsuit is scheduled for trial February 2017.

An MDL is established when there are a number of lawsuits with similar allegations. The cases are consolidated to one court before one judge. Streamlining lawsuits in this manner makes the process more efficient, speeding up complex litigation. The first several lawsuits to go to trial are known as bellwether cases. They are selected in order to predict how the majority of the litigation would proceed. As such, bellwether lawsuits are representative of the entire litigation.

In addition to the MDL, there is a mass tort program for Xarelto lawsuits underway in Philadelphia. Roughly 950 cases have been consolidated there so far. In both the mass tort and the MDL, plaintiffs allege that Xarelto presented a risk of uncontrollable, sometimes fatal bleeding. The lawsuits allege that the manufacturers were aware of this risk but failed to inform the patients, their physicians or the public.

The U.S. Food and Drug Administration (FDA) approved Xarelto in July 2011 to reduce the risk of blood clots, deep vein thrombosis and pulmonary embolism in patients undergoing knee and hip replacement surgeries. In November 2011, the agency approved the anticoagulant to reduce the risk of blood clots and related injuries in patients with atrial fibrillation, a type of abnormal heart rhythm.

The plaintiffs in the litigation allege that Xarelto was marketed as a superior alternative to warfarin, an older anticoagulant that requires regular blood monitoring and dietary restrictions. Xarelto and other new generation anticoagulants do not have these limitations, but plaintiffs take issue with the lack of an antidote to reverse the drug’s effects. This means that if a Xarelto patient suffers internal bleeding, there are no effective interventions to stop it, plaintiffs allege. Warfarin, plaintiffs point out, can be reversed with vitamin K. The lawsuits allege that the manufacturers failed to adequately warn patients or their physicians about these risks.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
I have to admit I've been dealing with lots of professional people in my lifetime and Tina Morace has to be up there as a number one candidate. she was very attentive, caring, and on top of her game. because of her amazing work I will definitely recommend Parker Waichman to my family, friends and colleagues. Thank you Tina!! Great Job!!
Casimiro Cuevas
2 years ago
5 Star Reviews 150
Alex explored the position of each defendant to assist in making an informed decision on my part. I appreciate his efforts to explore options and resolve the case. Thank you for your diligence.
asha bell
a year ago
5 Star Reviews 150
Good lawyers, I would recommend to anyone in need of legal services.
Guy Bradley
7 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038